Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

681 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlation of 18F-FDG uptake on PET/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer.
Mayoral M, Paredes P, Saco A, Fusté P, Perlaza P, Tapias A, Fernandez-Martinez A, Vidal L, Ordi J, Pavia J, Martinez-Roman S, Lomeña F. Mayoral M, et al. Among authors: vidal l. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Mar-Apr;37(2):80-86. doi: 10.1016/j.remn.2017.07.005. Epub 2017 Aug 30. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018. PMID: 28869177 English, Spanish.
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.
Frenel JS, Kim JW, Aryal N, Asher R, Berton D, Vidal L, Pautier P, Ledermann JA, Penson RT, Oza AM, Korach J, Huzarski T, Pignata S, Colombo N, Park-Simon TW, Tamura K, Sonke GS, Freimund AE, Lee CK, Pujade-Lauraine E. Frenel JS, et al. Among authors: vidal l. Ann Oncol. 2022 Oct;33(10):1021-1028. doi: 10.1016/j.annonc.2022.06.011. Epub 2022 Jun 27. Ann Oncol. 2022. PMID: 35772665 Free article. Clinical Trial.
SEOM guideline in ovarian cancer 2014.
Gonzalez-Martín A, Bover I, Del Campo JM, Redondo A, Vidal L; Spanish Society for Medical Oncology. Gonzalez-Martín A, et al. Among authors: vidal l. Clin Transl Oncol. 2014 Dec;16(12):1067-71. doi: 10.1007/s12094-014-1229-z. Epub 2014 Oct 29. Clin Transl Oncol. 2014. PMID: 25351169 Free PMC article.
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.
Romero I, Mallol P, Santaballa A, Del Campo JM, Mori M, González-Santiago S, Casado A, Vicente D, Ortega E, Herrero A, Guerra E, Barretina-Ginesta P, Rubio MJ, Martínez A, Bover I, Vidal L, Arcusa Á, Martín L, García Y, González-Martín A. Romero I, et al. Among authors: vidal l. Anticancer Drugs. 2019 Jul;30(6):628-635. doi: 10.1097/CAD.0000000000000794. Anticancer Drugs. 2019. PMID: 31008727
Correlation between clinical findings and magnetic resonance imaging for the assessment of local response after standard treatment in cervical cancer.
Valduvieco I, Biete A, Rios I, Llorente R, Rovirosa A, Pahisa J, Vidal L, Farrús B, Samper P. Valduvieco I, et al. Among authors: vidal l. Rep Pract Oncol Radiother. 2013 Jun 18;18(4):214-9. doi: 10.1016/j.rpor.2013.04.026. eCollection 2013. Rep Pract Oncol Radiother. 2013. PMID: 24416556 Free PMC article.
Solid cancer, antiphospholipid antibodies, and venous thromboembolism.
Font C, Vidal L, Espinosa G, Tàssies D, Monteagudo J, Farrús B, Visa L, Cervera R, Gascon P, Reverter JC. Font C, et al. Among authors: vidal l. Autoimmun Rev. 2011 Feb;10(4):222-7. doi: 10.1016/j.autrev.2010.10.006. Epub 2010 Oct 16. Autoimmun Rev. 2011. PMID: 20955822 Review.
681 results